EBITDA: Income before interest, taxes, depreciation and amortization.
ABVC BioPharma, Inc. (ABVC) had EBITDA of $-0.58M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.84M |
|
-- |
|
-- |
|
$0.69M |
|
$-0.69M |
|
$-0.25M |
|
$-0.94M |
|
$-0.89M |
|
$-0.94M |
|
$-0.94M |
|
$-0.94M |
|
$-0.89M |
|
$-0.69M |
|
|
EBITDA |
$-0.58M |
14.97M |
|
14.97M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$1.47M |
|
$8.17M |
|
$13.41M |
|
$14.88M |
|
$6.73M |
|
-- |
|
$0.19M |
|
$6.92M |
|
$7.96M |
|
$7.96M |
|
$7.96M |
|
14.65M |
|
| Cash Flow Statement Financials | |
$-0.54M |
|
-- |
|
$0.43M |
|
$0.86M |
|
$0.76M |
|
$-0.10M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.22 |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.87% |
|
-11.87% |
|
-6.35% |
|
-11.87% |
|
$0.54 |
|
$-0.04 |
|
$-0.04 |
|